For most of their lives, the two women have stayed tucked away indoors, sidelined by a rare blood disorder that makes the ...

Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday after the U.S. Food and Drug Administration approved the ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.

An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

When Laurie Stewart looks back at the past several months, she still struggles to believe how quickly everything changed.

Here is the full list of the health and wellness Startup Battlefield 200 selectees, along with a note on what made us select ...

OnlyMyHealth and HerZindagi by Jagran New Media’s initiative Period Party 30 – School Edition powered by Sirona attempted to ...

On average, a person will make about $50-$75 per appointment. However, the amount that you can make for donating plasma will ...

There can be too much of a good thing as some seemingly “good for you” foods could be secretly sabotaging your health if you ...

FDA approves Agios' Aqvesme for anemia in alpha and beta thalassemia, backed by Phase 3 data and a REMS safety program.